Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Lincoln Electric (NASDAQ:LECO) Raised to Buy at StockNews.com
Lincoln Electric (NASDAQ:LECO – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a...
Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note...
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a report issued...
RiceBran Technologies (NASDAQ:RIBT) Coverage Initiated by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Get Free Report) in a research report...
Barnwell Industries (NYSE:BRN) Now Covered by StockNews.com
Investment analysts at StockNews.com began coverage on shares of Barnwell Industries (NYSE:BRN – Get Free Report) in a research report...
UBS Group Upgrades Hugo Boss (OTCMKTS:BOSSY) to “Buy”
UBS Group upgraded shares of Hugo Boss (OTCMKTS:BOSSY – Free Report) from a neutral rating to a buy rating in...